Sort
27,075 grants matching “cholesterol”
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
$332,500Virginia Commonwealth University · R01 · FY2004 · AI
Alterations in synaptic growth and lipid-raft organization in a fly MLIV model
$332,500Kartik Venkatachalam · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · NS
Alterations in synaptic growth and lipid-raft organization in a fly MLIV model
$332,500Kartik Venkatachalam · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · NS
Statins and VEGF-induced cytoskeletal remodeling
$332,494Farhad R. Danesh · Northwestern University At Chicago · R01 · FY2006 · DK
Altered Hepatic Disposition of Statins by Diabetes Mellitus
$332,479Fatemeh Akhlaghi · University Of Rhode Island · R15 · FY2012 · GM
Quantitative analysis of metabotropic glutamate receptor activation and modulation
$332,466Reza Vafabakhsh · Northwestern University · R01 · FY2023 · GM
Quantitative analysis of metabotropic glutamate receptor activation and modulation
$332,466Reza Vafabakhsh · Northwestern University · R01 · FY2021 · GM
Quantitative analysis of metabotropic glutamate receptor activation and modulation
$332,466Reza Vafabakhsh · Northwestern University · R01 · FY2022 · GM
Quantitative analysis of metabotropic glutamate receptor activation and modulation
$332,466Reza Vafabakhsh · Northwestern University · R01 · FY2024 · GM
Diagnostic Cholesterol Efflux from Nasal Membrane in Cystic Fibrosis
$332,446James D Burgess · Case Western Reserve University · R01 · FY2011 · EB
Mechanisms of Co-Polymer-Mediated Neuroprotection
$332,424Jeremy D Marks · University Of Chicago · R01 · FY2010 · NS
SLO3 KO MOUSE: A TOOL TO REVEAL VOLTAGE-DEPENDENT PROCESSES IN SPERM FERTILITY
$332,424Celia M Santi · Washington University · R01 · FY2014 · HD
BIOLOGY OF 12-LIPOXYGENASE ISOZYMES
$332,405University Of Pennsylvania · R01 · FY2003 · HL
Diet Quality and CVD Risk Factors in a Family Based Weight Management Study
$332,375Alice H Lichtenstein · Tufts University Boston · R01 · FY2010 · HL
Non-Invasive Monitoring of NPC Disease Progression and Therapy
$332,357Theodore P Trouard · University Of Arizona · R01 · FY2010 · EB
Mechanism of Endocytic Trafficking of Cholesterol
$332,355Daniel S Ory · Washington University · R01 · FY2007 · HL
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
$332,345Virginia Commonwealth University · R01 · FY2005 · AI
Synthesis and Application of Novel Apolipoprotein Mimetics
$332,325M. Reza Ghadiri · Scripps Research Institute, The · R21 · FY2011 · HL
Modeling synaptic vesicles: how does alpha-Synuclein inhibit fusion?
$332,315Jonathan N Sachs · University Of Minnesota · R01 · FY2014 · NS
Using agent-based modeling to compare strategies that can reduce rural-urban disparities in cardiovascular disease
$332,237Donglan Zhang · Nyu Long Island School Of Medicine · R01 · FY2022 · MD
Mechanisms of regulation of LRH-1, Nanog and SF-1 by DAX-1
$332,175Robert J Fletterick · University Of California, San Francisco · R01 · FY2009 · DK
The influence of TCR spatial organization on the T cell responses
$332,165Jonathan P Schneck · Johns Hopkins University · P01 · FY2009 · AI
GENOMIC RESOURCE DEVELOPMENT IN THE LABORATORY OPOSSUM
$332,132Southwest Foundation For Biomedical Res · R24 · FY2003 · RR
GENOMIC RESOURCE DEVELOPMENT IN THE LABORATORY OPOSSUM
$332,132Southwest Foundation For Biomedical Res · R24 · FY2004 · RR
Targeting Warburg Effect to Reverse Stress-Induced Insulin Resistance in Burns
$332,101Masao Kaneki · Massachusetts General Hospital · R01 · FY2019 · GM